Evidence map›Paper›PMID 19883709›Full record

ArticlePeptides2010

The metabolic phenotype of SCD1-deficient mice is independent of melanin-concentrating hormone.

Melissa B Glier, Pavlos Pissios, Sandra L Babich, Marcia L E Macdonald, Michael R Hayden, Eleftheria Maratos-Flier, William T Gibson

Abstract read
In one paragraph

Article in Peptides, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Melissa B GlierDepartment of Medical Genetics, Child and Family Research Institute, University of British Columbia, Canada. glier@interchange.ubc.ca
Pavlos Pissios
Sandra L Babich
Marcia L E Macdonald
Michael R Hayden
Eleftheria Maratos-Flier
William T Gibson
University of British Columbia · CABeth Israel Deaconess Medical Center · US

Funding

Transgenic CoreP30DK057521 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI FLOREZ, JOSE CARLOS · 2000 to 2019
$31.4M
CIHR OOP-79614NIDDK NIH HHS P30 DK057521
6 · The paper itself

Abstract

We propose that deletion of pro-melanin-concentrating hormone (pMCH) would increase energy expenditure and further improve glucose tolerance in mice lacking stearoyl-coA desaturase-1 (SCD1). To test our hypothesis, we bred and metabolically challenged Pmch-/-; Scd1-/- double-knockout mice, with comparison to Pmch-/- mice; Scd1-/- mice and C57Bl/6J controls. Deletion of both Pmch and Scd1 increased both food intake and energy expenditure relative to control mice. Pmch-/-; Scd1-/- double-knockout mice had improved glucose tolerance relative to control mice. The majority of the metabolic effects were contributed by inactivation of the Scd1 gene. We conclude that the increased food intake and increased energy expenditure of Scd1-/- mice are independent of the neuropeptide melanin-concentrating hormone.

Indexed as

AnimalsBody WeightEatingEnergy MetabolismFemaleGenotypeGlucose Tolerance TestHomeostasisHumansHypothalamic HormonesInsulinMiceMice, Inbred C57BLMice, KnockoutMotor ActivityProtein PrecursorsHypothalamic HormonesInsulinmelanin-concentrating hormone precursorsProtein PrecursorsStearoyl-CoA Desaturase

Identifiers

PMID19883709
PMCPMC4096855
OpenAlexW2093325311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.